Chairman Konowiecki exits executive role; remains Board Chair, equity continues

Alignment Healthcare, Inc.

Joseph Konowiecki ends executive role (strategic network & business development) on Dec 31, 2023; remains Board Chair.
No cash severance; unvested equity awards continue vesting as long as he serves as a service provider or Board member.
He will not receive the 2023 annual equity award issued to other directors but will receive the 2023 cash bonus.
2023 bonus is subject to CMS Star ratings holdback and adjustments; initial payout expected in March 2024.
Post-Dec 31, he will be compensated per Non-Employee Director Compensation Policy effective Jan 1, 2024.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph Konowiecki

Chairman of the Board

ALHC · Alignment Healthcare, Inc.

Effective: 2023-12-31
Filed: December 29, 2023, 6:59 PM ET

Pursuant to the Amendment, Mr. Konowiecki will no longer serve in an executive role leading strategic network and business development (the "Executive Role"), effective as of December 31, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Konowiecki changed role as Chairman of the Board at Alignment Healthcare, Inc..

Action: no longer serve in an executive role
Role: Chairman of the Board

Exact text from the filing

Pursuant to the Amendment, Mr. Konowiecki will no longer serve in an executive role leading strategic network and business development (the "Executive Role"), effective as of December 31, 2023

View on SEC.gov

Alignment Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-073907

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.